Re: Biogen looks to FDA for approval of early Alzheimers drug.
in response to
by
posted on
Oct 22, 2019 11:19AM
,,,,acccchhhh,,,,not sure how promising such a drug will be if swelling of the brain is a side effect,,,,,especially long term exposure under high dosage,,,,,,,,maybe better as a viagra competitor!!,,,,,,,,however ,, I have consulted with my crystal ball,,,and,,,, I read into it that we will be very pleasantly surprised with our BoM data,,,,and this is the caveat,,,how the market will interpret it will be for another reading after rolling and incinerating a regular sized fat one,,,later today maybe,,,as previously discussed here the AGM may give us the best hint as to the level of excitement we should be exhibiting prior to mid November,,,,,,,,,!!,,,,the crystal ball thing is not investment advice by the way,,,,,,,,,